Skip Header

Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q15311 (RBP1_HUMAN)

Last modified February 9, 2010. Version 84. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    RalA-binding protein 1
      Short name=RalBP1
Alternative name(s):
    Ral-interacting protein 1
    76 kDa Ral-interacting protein
    Dinitrophenyl S-glutathione ATPase
      Short name=DNP-SG ATPase
Gene names
Name: RALBP1
Synonyms: RLIP1, RLIP76
OrganismHomo sapiens (Human) [Complete proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length655 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Can activate specifically hydrolysis of GTP bound to RAC1 and CDC42, but not RALA. Mediates ATP-dependent transport of S-(2,4-dinitrophenyl)-glutathione (DNP-SG) and doxorubicin (DOX) and is the major ATP-dependent transporter of glutathione conjugates of electrophiles (GS-E) and DOX in erythrocytes. Can catalyze transport of glutathione conjugates and xenobiotics, and may contribute to the multidrug resistance phenomenon. Serves as a scaffold protein that brings together proteins forming an endocytotic complex during interphase and also with CDC2 to switch off endocytosis, One of its substrates would be EPN1/Epsin. Ref.1 Ref.5 Ref.6

Subunit structure

Interacts with the GTP-bound form of RALA, RALB, CDC42 and RAC1. Interacts with REPS1 and REPS2 and this does not affect the Ral-binding activity. Interacts with DAB2IP. Interacts with catalytically active CCNB1 and CDC2 during mitosis. Interacts with EPN1, NUMB and TFAP2A during interphase and mitosis. Ref.1 Ref.5 Ref.4 Ref.7

Subcellular location

Membrane; Peripheral membrane protein Ref.6.

Tissue specificity

Expressed ubiquitously but at low levels. Shows a strong expression in the erythrocytes. Ref.6

Sequence similarities

Contains 1 Rho-GAP domain.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Initiator methionine11Removed Ref.2
Chain2 – 655654RalA-binding protein 1
PRO_0000056733

Regions

Domain192 – 380189Rho-GAP
Region403 – 49997Interacts with RalA
Compositional bias164 – 1718Poly-Lys

Amino acid modifications

Modified residue111Phosphoserine Ref.13
Modified residue271Phosphothreonine Ref.9
Modified residue291Phosphoserine Ref.13 Ref.9
Modified residue301Phosphoserine Ref.13
Modified residue341Phosphoserine Ref.13 Ref.10
Modified residue621Phosphoserine Ref.10
Modified residue921Phosphoserine Ref.13 Ref.8 Ref.11 Ref.15
Modified residue931Phosphoserine Ref.13 Ref.8 Ref.11 Ref.15
Modified residue2701Phosphotyrosine Ref.13
Modified residue2801Phosphothreonine Ref.13
Modified residue4631Phosphoserine Ref.13
Modified residue6451Phosphoserine

Natural variations

Natural variant6171A → V: dbSNP rs35867116.
VAR_049147

Sequences

Sequence LengthMass (Da)Tools
Q15311-1 [UniParc].

Last modified January 23, 2007. Version 3.
Checksum: EC6F75329FD8D062

FASTA65576,063
        10         20         30         40         50         60 
MTECFLPPTS SPSEHRRVEH GSGLTRTPSS EEISPTKFPG LYRTGEPSPP HDILHEPPDV 

        70         80         90        100        110        120 
VSDDEKDHGK KKGKFKKKEK RTEGYAAFQE DSSGDEAESP SKMKRSKGIH VFKKPSFSKK 

       130        140        150        160        170        180 
KEKDFKIKEK PKEEKHKEEK HKEEKHKEKK SKDLTAADVV KQWKEKKKKK KPIQEPEVPQ 

       190        200        210        220        230        240 
IDVPNLKPIF GIPLADAVER TMMYDGIRLP AVFRECIDYV EKYGMKCEGI YRVSGIKSKV 

       250        260        270        280        290        300 
DELKAAYDRE ESTNLEDYEP NTVASLLKQY LRDLPENLLT KELMPRFEEA CGRTTETEKV 

       310        320        330        340        350        360 
QEFQRLLKEL PECNYLLISW LIVHMDHVIA KELETKMNIQ NISIVLSPTV QISNRVLYVF 

       370        380        390        400        410        420 
FTHVQELFGN VVLKQVMKPL RWSNMATMPT LPETQAGIKE EIRRQEFLLN CLHRDLQGGI 

       430        440        450        460        470        480 
KDLSKEERLW EVQRILTALK RKLREAKRQE CETKIAQEIA SLSKEDVSKE EMNENEEVIN 

       490        500        510        520        530        540 
ILLAQENEIL TEQEELLAME QFLRRQIASE KEEIERLRAE IAEIQSRQQH GRSETEEYSS 

       550        560        570        580        590        600 
ESESESEDEE ELQIILEDLQ RQNEELEIKN NHLNQAIHEE REAIIELRVQ LRLLQMQRAK 

       610        620        630        640        650 
AEQQAQEDEE PEWRGGAVQP PRDGVLEPKA AKEQPKAGKE PAKPSPSRDR KETSI 

« Hide

References

« Hide 'large scale' references
[1]"Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity."
Jullien-Flores V., Dorseuil O., Romero F., Letourneur F., Saragosti S., Berger R., Tavitian A., Gacon G., Camonis J.H.
J. Biol. Chem. 270:22473-22477(1995) [PubMed: 7673236] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH RALA.
[2]"Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin."
Awasthi S., Cheng J., Singhal S.S., Saini M.K., Pandya U., Pikula S., Bandorowicz-Pikula J., Singh S.V., Zimniak P., Awasthi Y.C.
Biochemistry 39:9327-9334(2000) [PubMed: 10924126] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, PROTEIN SEQUENCE OF 2-15; 409-438 AND 472-486.
Tissue: Bone marrow.
[3]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Placenta.
[4]"Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral."
Ikeda M., Ishida O., Hinoi T., Kishida S., Kikuchi A.
J. Biol. Chem. 273:814-821(1998) [PubMed: 9422736] [Abstract]
Cited for: INTERACTION WITH REPS2.
Tissue: Brain.
[5]"RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis."
Rosse C., L'Hoste S., Offner N., Picard A., Camonis J.
J. Biol. Chem. 278:30597-30604(2003) [PubMed: 12775724] [Abstract]
Cited for: FUNCTION, INTERACTION WITH CCNB1; CDC2; EPN1; NUMB AND TFAP2A.
[6]"RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes."
Sharma R., Singhal S.S., Cheng J., Yang Y., Sharma A., Zimniak P., Awasthi S., Awasthi Y.C.
Arch. Biochem. Biophys. 391:171-179(2001) [PubMed: 11437348] [Abstract]
Cited for: FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY.
[7]"AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation."
Zhang H., Zhang R., Luo Y., D'Alessio A., Pober J.S., Min W.
J. Biol. Chem. 279:44955-44965(2004) [PubMed: 15310755] [Abstract]
Cited for: INTERACTION WITH DAB2IP.
[8]"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.
Cell 127:635-648(2006) [PubMed: 17081983] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92 AND SER-93, MASS SPECTROMETRY.
Tissue: Epithelium.
[9]"Phosphoproteome of resting human platelets."
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A.
J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-27 AND SER-29, MASS SPECTROMETRY.
Tissue: Platelet.
[10]"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis."
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III
J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34 AND SER-62, MASS SPECTROMETRY.
[11]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92 AND SER-93, MASS SPECTROMETRY.
[12]Colinge J., Superti-Furga G., Bennett K.L.
Submitted (OCT-2008) to UniProtKB
Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY.
[13]"Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.
Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-29; SER-30; SER-34; SER-92; SER-93; TYR-270; THR-280 AND SER-463, MASS SPECTROMETRY.
[14]"Large-scale proteomics analysis of the human kinome."
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H.
Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29; SER-92; SER-93 AND SER-645, MASS SPECTROMETRY.
[15]"Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K.
Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92 AND SER-93, MASS SPECTROMETRY.
Tissue: T-cell.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
L42542 mRNA. Translation: AAB00103.1.
BC013126 mRNA. Translation: AAH13126.1.
IPIIPI00009544.
PIRF59435.
RefSeqNP_006779.1.
UniGeneHs.528993
Hs.719181

3D structure databases

SMRQ15311. Positions 184-352.
ModBaseSearch...

Protein-protein interaction databases

IntActQ15311. 3 interactions.
STRINGQ15311.

Protein family/group databases

TCDB9.A.1.1.1. non ABC multidrug exporter (N-MDE) family.

PTM databases

PhosphoSiteQ15311.

Proteomic databases

PeptideAtlasQ15311.
PRIDEQ15311.

Genome annotation databases

EnsemblENST00000019317; ENSP00000019317; ENSG00000017797; Homo sapiens. [Genome view]
ENST00000383432; ENSP00000372924; ENSG00000017797; Homo sapiens. [Genome view]
GeneID10928.
KEGGhsa:10928.
UCSCuc002kob.1. human.

Organism-specific databases

CTD10928.
GeneCardsGC18P009465.
H-InvDBHIX0014325.
HGNCHGNC:9841. RALBP1.
MIM605801. gene.
PharmGKBPA34199.
GenAtlasSearch...

Phylogenomic databases

eggNOGprNOG10919.
HOGENOMHBG713891.
HOVERGENQ15311.
InParanoidQ15311.
OMATQAGIKE.
OrthoDBEOG94BDMF.
PhylomeDBQ15311.

Enzyme and pathway databases

ReactomeREACT_11044. Signaling by Rho GTPases.

Gene expression databases

ArrayExpressQ15311.
BgeeQ15311.
CleanExHS_RALBP1.
GenevestigatorQ15311.
GermOnlineENSG00000017797. Homo sapiens.

Family and domain databases

InterProIPR008936. Rho_GTPase_activation_prot.
IPR000198. RhoGAP.
[Graphical view]
Gene3DG3DSA:1.10.555.10. RhoGAP. 1 hit.
PfamPF00620. RhoGAP. 1 hit.
[Graphical view]
SMARTSM00324. RhoGAP. 1 hit.
[Graphical view]
PROSITEPS50238. RHOGAP. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio41515.
SOURCESearch...

Entry information

Entry nameRBP1_HUMAN
AccessionPrimary (citable) accession number: Q15311
Entry history
Integrated into UniProtKB/Swiss-Prot: August 15, 2003
Last sequence update: January 23, 2007
Last modified: February 9, 2010
This is version 84 of the entry and version 3 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 18

Human chromosome 18: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents